WuXi XDC Cayman Inc. (HKG:2268)

Hong Kong · Delayed Price · Currency is HKD

59.55

+1.90 (3.30%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Pharmaceuticals	4.05B	2.12B	990.42M	311.13M	96.35M
Pharmaceuticals Growth	90.80%	114.44%	218.33%	222.91%	-
Total	4.05B	2.12B	990.42M	311.13M	96.35M
Total Growth	90.80%	114.44%	218.33%	222.91%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
North America	1.98B	726.11M	259.52M	5.40M	-
North America Growth	173.10%	179.79%	4706.83%	-	-
Europe	610.21M	459.84M	128.65M	5.27M	-
Europe Growth	32.70%	257.44%	2343.44%	-	-
The PRC	1.13B	849.07M	566.48M	291.10M	96.35M
The PRC Growth	33.40%	49.89%	94.60%	202.12%	-
Rest of The World	326.46M	88.82M	35.78M	9.36M	-
Rest of The World Growth	267.54%	148.25%	282.14%	-	-
Total	4.05B	2.12B	990.42M	311.13M	96.35M
Total Growth	90.80%	114.44%	218.33%	222.91%	-

Source: S&P Global Market Intelligence.